(Q40462719)

20 September 2017

1 reference

title

Liposomes and ISCOMS as vaccine formulations (English)

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

5 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7640293

5 July 2024

author name string

G. F. Kersten

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7640293

5 July 2024

D. J. Crommelin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7640293

5 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7640293

5 July 2024

publication date

1 July 1995

1 reference

20 September 2017

17 July 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7640293

full work available at URL

5 July 2024

number of pages

22

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0304415795000029?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

https://api.elsevier.com/content/article/PII:0304415795000029?httpAccept=text/plain

5 July 2024

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Biochimica et Biophysica Acta

5 July 2024

published in

1 reference

20 September 2017

volume

1241

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

117-138

1 reference

Introduction of soluble protein into the class I pathway of antigen processing and presentation

20 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0092-8674(88)91043-4

A comparison of commercially available adjuvants for use in research

3

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis

5 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

5 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The molecular biology of poliovaccines

5 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective

5 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

5 July 2024

Vaccine adjuvants.

12

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Adjuvants--a balance between toxicity and adjuvanticity

5 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Current status of immunological adjuvants

5 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Interleukin 2 increases protection against experimental rabies.

5 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Effective subunit vaccines against an enveloped animal virus

5 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells

5 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The cell biology of antigen processing and presentation

5 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum

5 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation

5 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens

5 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones

5 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Cells process exogenous proteins for recognition by cytotoxic T lymphocytes

5 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Antigen recognition by class I-restricted T lymphocytes

5 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

19 Reconstitution of membrane proteins

5 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Lipidic intramembranous particles

5 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposome-mediated elimination of macrophages

5 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications

5 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Recent aspects in the use of liposomes in biotechnology and medicine

5 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomes and biotherapeutics

5 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Single bilayer vesicles prepared without sonication. Physico-chemical properties

5 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

A molecular model for vesicle formation.

5 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes

5 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomes as immunological adjuvants

5 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The effect of surface charges of liposomes in immunopotentiation

5 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

An alternative procedure for the preparation of immunogenic liposomal model membranes

5 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunogenicity of liposomes and iscoms containing the major outer membrane protein of Neisseria gonorrhoeae: influence of protein content and liposomal bilayer composition

5 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Effect of liposomes on lymphocytes: induction of proliferation of B lymphocytes and potentiation of the cytotoxic response of T lymphocytes to alloantigens

5 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response

5 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomes as immunological adjuvants: antigen incorporation studies

5 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomes in immunology: Evidence that their adjuvant effect results from surface exposition of the antigens

5 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A

5 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunologic response to protein immobilized on the surface of liposomes via covalent azo-bonding

5 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Comparative effect on humoral response of four different proteins covalently linked on BSA-containing liposomes

5 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen

5 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

5 July 2024

64

20

95

Kotani

1977

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunomodulating properties of substances to be used in combination with liposomes.

5 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigens

5 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes

5 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunoadjuvant activity of a liposomal IL-6 formulation

5 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomes containing lipid A as a potent non-toxic adjuvant

5 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes

5 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Interleukin-2-containing liposomes: interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccines

5 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro

5 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages

5 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages

5 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes effects of lanthanum and gadolinium salts

5 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size

5 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay

5 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Interaction of liposomes with Kupffer cells in vitro

5 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Enzyme-containing Liposomes alleviate a Model for Storage Disease

5 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal

5 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement

5 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposome-cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes

5 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The role of macrophages in promoting the antibody response mediated by liposome-associated protein antigens

5 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The macrophage as the principal antigen-presenting cell for liposome-encapsulated antigen

5 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen

5 July 2024

97

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomal delivery of soluble protein antigens for class I MHC-mediated antigen presentation

5 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The dendritic cell system and its role in immunogenicity

5 July 2024

100

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The liposome-mediated macrophage 'suicide' technique

5 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Opsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cells

5 July 2024

104

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Influence of lipid composition on opsonophagocytosis of liposomes

5 July 2024

105

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomal encapsulation augments delayed hypersensitivity reactions to tuberculin proteins

5 July 2024

112

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunoliposomes with different acid sensitivities as probes for the cellular endocytic pathway

5 July 2024

114

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Structural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols

5 July 2024

115

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact

5 July 2024

117

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules

5 July 2024

118

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Lipid polymorphism and the functional roles of lipids in biological membranes

5 July 2024

119

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Antigen presentation by B cells and macrophages of cytochrome c and its antigenic fragment when conjugated to the surface of liposomes

5 July 2024

121

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Antigen presentation by liposomes: inhibition with antibodies

5 July 2024

122

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The Journal of Molecular and Cellular Immunology

5 July 2024

123

2

191

Walden

1986

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Mouse response to influenza immunosomes.

5 July 2024

124

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen

5 July 2024

125

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The Interaction of Influenza Virus Haemagglutinin with Phospholipid Vesicles -- Morphological and Immunological Studies

5 July 2024

126

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant

5 July 2024

128

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382).

5 July 2024

129

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses

5 July 2024

130

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens

5 July 2024

131

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks

5 July 2024

132

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Inactivated virosome hepatitis A vaccine

5 July 2024

133

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Glycoproteins of human parainfluenza virus type 3: affinity purification, antigenic characterization and reconstitution into lipid vesicles

5 July 2024

134

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Comparative analysis of the immunostimulatory properties of different adjuvants on the immunogenicity of a prototype parainfluenza virus type 3 subunit vaccine

5 July 2024

135

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Cell-mediated cytotoxicity against targets bearing Sendai virus glycoproteins in the absence of viral infection

5 July 2024

136

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigs

5 July 2024

139

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Disposition of antigen-presenting liposomes in vivo: effect on presentation of herpes simplex virus antigen rgD.

5 July 2024

140

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2

5 July 2024

141

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies

5 July 2024

142

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes

5 July 2024

145

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity

5 July 2024

146

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants

5 July 2024

148

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations

5 July 2024

149

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes

5 July 2024

150

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Vaccination of mice with liposome-entrapped adult antigens of Nippostrongylus brasiliensis

5 July 2024

153

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A.

5 July 2024

155

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes

5 July 2024

156

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Some immunogenic acid biochemical properties of tumor-associated transplantation antigens (TATA) obtained in soluble form or solubilized from two methylcholanthrene-induced sarcomas, Meth A and CI-4

5 July 2024

159

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Carrier and adjuvant properties of liposome-borne tumor-specific antigens

5 July 2024

161

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

In vivo induction of tumor-specific immunity by glycolipid extracts of SV40-transformed cells

5 July 2024

165

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). II. Association of sv40-tsta activity with liposomes containing vsv glycolipids

5 July 2024

166

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

5 July 2024

167

52

6287

Zhou

1992

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Vaccination against enteric bacterial diseases.

5 July 2024

168

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The common mucosal immune system and current strategies for induction of immune responses in external secretions

5 July 2024

169

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Enhancement by lipid A of mucosal immunogenicity of liposome-associated cholera toxin

5 July 2024

173

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Local response in rat to liposome-associated Streptococcus mutans polysaccharide-protein conjugate.

5 July 2024

176

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The intestinal and serum humoral immune response of mice to orally administered antigens in liposomes: II. The response to liposome-entrapped bacterial proteins

5 July 2024

178

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The intestinal and serum humoral immune response of mice to systemically and orally administered antigens in liposomes: I. The response to liposome-entrapped soluble proteins

5 July 2024

179

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Serum and salivary antibody responses in rats orally immunized with Streptococcus mutans carbohydrate protein conjugate associated with liposomes.

5 July 2024

182

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response.

5 July 2024

183

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Intranasal immunization with proteoliposomes protects against influenza

5 July 2024

184

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Stimulation of secretory antibodies against Bordetella pertussis antigens in the lungs of mice after oral or intranasal administration of liposome-incorporated cell-surface antigens

5 July 2024

185

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The preparation and properties of niosomes--non-ionic surfactant vesicles

5 July 2024

187

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control

5 July 2024

189

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Preparation of cell-size unilamellar liposomes with high captured volume and defined size distribution

5 July 2024

191

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomes as vaccine carriers. Incorporation of soluble and particulate antigens in giant vesicles

5 July 2024

192

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Heterologous protection against influenza by injection of DNA encoding a viral protein

5 July 2024

193

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

5 July 2024

195

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposomes as agents of DNA transfer

5 July 2024

198

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

5 July 2024

199

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.

5 July 2024

201

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

On the structure of immune-stimulating saponin-lipid complexes (iscoms)

5 July 2024

202

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

5 July 2024

205

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Quaternary structure of the immunostimulating complex (iscom).

5 July 2024

210

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Assay of detergents by rocket electrophoresis in agarose gels containing red blood cells: "rocket hemolysis"

5 July 2024

211

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Influenza virus ISCOMs: biochemical characterization

5 July 2024

212

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms

5 July 2024

213

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid

5 July 2024

214

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene

5 July 2024

215

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Iscom immunization with synthetic peptides representing measles virus hemagglutinin

5 July 2024

216

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier

5 July 2024

217

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunopotentiation of synthetic oligopeptides by chemical conjugation to iscoms

5 July 2024

218

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Vaccination of mice against malaria with soluble antigens. I. The effect of detergent, route of injection, and adjuvant

5 July 2024

222

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

5 July 2024

Saponin

224

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

An in vitro study of immunomodulatory effects of some saponins

5 July 2024

226

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunopotentiation by SGP and Quil A. II. Identification of responding cell populations.

5 July 2024

227

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens

5 July 2024

228

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants

5 July 2024

230

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunomodulatory effects of orally-administered saponins and nonspecific resistance against rabies infection.

5 July 2024

233

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killed Plasmodium yoelii vaccine in the mouse

5 July 2024

234

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Long-term toxicity study quillaia extract in rats

5 July 2024

237

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Long-term toxicity study of quillaia extract in mice

5 July 2024

238

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Local reactions of the saponin Quil A and a Quil A containing iscom measles vaccine after intramuscular injection of rats: a comparison with the effect of DPT-polio vaccine

5 July 2024

239

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates

5 July 2024

241

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats

5 July 2024

243

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

5 July 2024

246

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

An acylated triterpenoid saponin from Quillaja saponaria

5 July 2024

247

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Structure of desacylsaponins obtained from the bark of Quillaja saponaria

5 July 2024

249

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Adjuvant activity of QS-21 isomers

5 July 2024

250

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice

5 July 2024

251

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Interactions between Immune-Stimulating Complexes (ISCOMs) and Peritoneal Mononuclear Leucocytes

5 July 2024

252

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms.

5 July 2024

253

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus

5 July 2024

254

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Humoral immune response elicited in rats by measles viral membrane antigens presented in liposomes and ISCOMs

5 July 2024

255

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Inflammatory response and antigen localization following immunization with influenza virus ISCOMs

5 July 2024

256

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells

5 July 2024

257

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms

5 July 2024

258

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells

5 July 2024

260

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Processing of liposome-encapsulated antigens targeted to specific subcellular compartments

5 July 2024

261

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines

5 July 2024

263

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

5 July 2024

264

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition

5 July 2024

265

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The iscom structure as an immune-enhancing moiety: experience with viral systems

5 July 2024

266

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

An immune stimulating complex (ISCOM) subunit rabies vaccine protects dogs and mice against street rabies challenge

5 July 2024

267

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.

5 July 2024

268

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Seal vaccination success.

5 July 2024

270

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Canine distemper virus ISCOMs induce protection in harbour seals (Phoca vitulina) against phocid distemper but still allow subsequent infection with phocid distemper virus-1

5 July 2024

272

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Canine Distemper Virus (CDV) Immune-stimulating Complexes (Iscoms), but Not Measles Virus Iscoms, Protect Dogs against CDV Infection

5 July 2024

273

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine

5 July 2024

274

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Vaccination of rabbits with a bovine herpesvirus type 1 subunit vaccine: adjuvant effect of ISCOMs

5 July 2024

275

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Control of infectious bovine rhinotracheitis in calves with a BHV-1 subunit-ISCOM vaccine

5 July 2024

276

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Biochemical characterization of herpes simplex virus type-1-immunostimulating complexes (ISCMOs): a multi-glycoprotein structure

5 July 2024

277

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations

5 July 2024

278

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine

5 July 2024

279

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMs) containing the major viral glycoproteins

5 July 2024

280

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Evaluation of glycoprotein gII ISCOMs subunit vaccine for pseudorabies in pig

5 July 2024

281

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes

5 July 2024

282

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Formation and characterization of FeLV ISCOMs

5 July 2024

283

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine

5 July 2024

284

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Enhancement after feline immunodeficiency virus vaccination

5 July 2024

287

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120).

5 July 2024

289

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Incorporation of soluble antigens into ISCOMs: HIV gp120 ISCOMs induce virus neutralizing antibodies

5 July 2024

290

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Preparation and properties of immune-stimulating complexes containing hepatitis B virus surface antigen

5 July 2024

291

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Controlled organization of multimolecular complexes of enveloped virus glycoproteins: study of immunogenicity

5 July 2024

292

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Influenza virus ISCOMs: antibody response in animals

5 July 2024

293

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice

5 July 2024

294

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Neutralizing response of rabbits to an experimental rubella subunit vaccine made from immunostimulating complexes

5 July 2024

295

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes

5 July 2024

296

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Vaccination of Balb/c mice against enteroviral mediated myocarditis

5 July 2024

297

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice

5 July 2024

299

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Iscom (immunostimulating complex) vaccines containing mono- or polyvalent pili of enterotoxigenic E. coli; immune response of rabbit and swine

5 July 2024

300

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Trial of a novel experimental Toxoplasma iscom vaccine in pregnant sheep

5 July 2024

301

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immune response after immunization with an experimental Toxoplasma gondii ISCOM vaccine

5 July 2024

302

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunizing effects in mice of two Toxoplasma gondii iscom preparations

5 July 2024

303

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes.

5 July 2024

304

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunogenicity of a hybrid Plasmodium falciparum malaria antigen

5 July 2024

305

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA.

5 July 2024

306

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

ISCOMS — a novel strategy for mucosal immunization?

5 July 2024

307

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms).

5 July 2024

308

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes

5 July 2024

309

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus

5 July 2024

310

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM)

5 July 2024

311

1 reference

https://api.crossref.org/works/10.1016/0304-4157(95)00002-9

5 July 2024

Identifiers

1 reference

20 September 2017

1 reference